Constancy and variability of gallbladder ejection fraction

Impact on diagnosis and therapy

Gerbail T. Krishnamurthy, Shakuntala Krishnamurthy, Paul Brown

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The main objective of this study was to test the constancy and variability of gallbladder (GB) ejection fraction (EF) in long-term studies to (a) determine whether EF ever becomes normal once it is low, (b) determine how long it takes for the EF to become abnormal once it is found to be normal, (c) explore the cause of low EF, and (d) define objective parameters for biliary and nonbiliary abdominal pain. Methods: Fifty-two patients (42 women, 10 men) who underwent quantitative cholescintigraphy twice (total studies, 104), over a mean period of 38.54 mo between studies, were chosen for retrospective analysis. They were divided into the following groups: control (n = 13; nonbiliary abdominal pain), chronic acalculous cholecystitis (CAC) (n = 27; biliary abdominal pain), chronic calculous cholecystitis (CCC) (n = 6; biliary abdominal pain), and opioid (n = 6; nonbiliary abdominal pain). The last group had received an opioid before cholecystokinin-8 (CCK-8) infusion in one study but not in the other study. A GBEF value of ≥35% was considered normal with a 3-min infusion and ≥50% as normal with a 10-min infusion of CCK-8. Results: The mean GBEF value was reproducible between the 2 sequential studies in the control group (66.0% ± 20.5% vs. 73.9% ± 17.7%), CAC group (24.4% ± 22.3% vs. 16.9% ± 10.9%), and CCC group (20.8% ± 20.9% vs. 27.5% ± 34.5%) but not in the opioid group (14.8% ± 14.6% vs. 56.5% ± 31.7%). The severity of GBEF reduction in CAC increased with time: 7.2% ± 8.1% within 12 mo, 16.1% ± 14.9% in 13-47 mo, and 23.5% ± 21.3% in 48-168 mo. None of the 27 patients with CAC developed a gallstone as detected by ultrasound during the study period. In 5 patients with CAC, a mean period of 52.6 ± 28.9 mo was required for conversion from normal to a low EF. CCK-induced cystic duct spasm is the etiology for low EF in both CAC and CCC. Conclusion: Normal and low GBEF values are reproducible in long-term studies. Once the EF reaches a low value, it does not return to normal, and a normal value requires many years to become abnormal. CCK-induced cystic duct spasm is the cause of low GBEF in CAC and CCC, and the severity of EF reduction is similar for both. Exclusion of opioid intake immediately before the study is critical before attributing a low GBEF value to an irreversible GB motor dysfunction.

Original languageEnglish (US)
Pages (from-to)1872-1877
Number of pages6
JournalJournal of Nuclear Medicine
Volume45
Issue number11
StatePublished - Nov 1 2004

Fingerprint

Acalculous Cholecystitis
Gallbladder
Cholecystitis
Abdominal Pain
Opioid Analgesics
Cystic Duct
Spasm
Therapeutics
Control Groups
Gallstones
Reference Values

Keywords

  • Acalculous cholecystitis
  • Calculous cholecystitis
  • Cholecystokinin
  • Cholescintigraphy
  • Gallbladder ejection fraction
  • Opioids

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Krishnamurthy, G. T., Krishnamurthy, S., & Brown, P. (2004). Constancy and variability of gallbladder ejection fraction: Impact on diagnosis and therapy. Journal of Nuclear Medicine, 45(11), 1872-1877.

Constancy and variability of gallbladder ejection fraction : Impact on diagnosis and therapy. / Krishnamurthy, Gerbail T.; Krishnamurthy, Shakuntala; Brown, Paul.

In: Journal of Nuclear Medicine, Vol. 45, No. 11, 01.11.2004, p. 1872-1877.

Research output: Contribution to journalArticle

Krishnamurthy, GT, Krishnamurthy, S & Brown, P 2004, 'Constancy and variability of gallbladder ejection fraction: Impact on diagnosis and therapy', Journal of Nuclear Medicine, vol. 45, no. 11, pp. 1872-1877.
Krishnamurthy, Gerbail T. ; Krishnamurthy, Shakuntala ; Brown, Paul. / Constancy and variability of gallbladder ejection fraction : Impact on diagnosis and therapy. In: Journal of Nuclear Medicine. 2004 ; Vol. 45, No. 11. pp. 1872-1877.
@article{c0c7e939ba9b4bc79d792d31159e5f69,
title = "Constancy and variability of gallbladder ejection fraction: Impact on diagnosis and therapy",
abstract = "The main objective of this study was to test the constancy and variability of gallbladder (GB) ejection fraction (EF) in long-term studies to (a) determine whether EF ever becomes normal once it is low, (b) determine how long it takes for the EF to become abnormal once it is found to be normal, (c) explore the cause of low EF, and (d) define objective parameters for biliary and nonbiliary abdominal pain. Methods: Fifty-two patients (42 women, 10 men) who underwent quantitative cholescintigraphy twice (total studies, 104), over a mean period of 38.54 mo between studies, were chosen for retrospective analysis. They were divided into the following groups: control (n = 13; nonbiliary abdominal pain), chronic acalculous cholecystitis (CAC) (n = 27; biliary abdominal pain), chronic calculous cholecystitis (CCC) (n = 6; biliary abdominal pain), and opioid (n = 6; nonbiliary abdominal pain). The last group had received an opioid before cholecystokinin-8 (CCK-8) infusion in one study but not in the other study. A GBEF value of ≥35{\%} was considered normal with a 3-min infusion and ≥50{\%} as normal with a 10-min infusion of CCK-8. Results: The mean GBEF value was reproducible between the 2 sequential studies in the control group (66.0{\%} ± 20.5{\%} vs. 73.9{\%} ± 17.7{\%}), CAC group (24.4{\%} ± 22.3{\%} vs. 16.9{\%} ± 10.9{\%}), and CCC group (20.8{\%} ± 20.9{\%} vs. 27.5{\%} ± 34.5{\%}) but not in the opioid group (14.8{\%} ± 14.6{\%} vs. 56.5{\%} ± 31.7{\%}). The severity of GBEF reduction in CAC increased with time: 7.2{\%} ± 8.1{\%} within 12 mo, 16.1{\%} ± 14.9{\%} in 13-47 mo, and 23.5{\%} ± 21.3{\%} in 48-168 mo. None of the 27 patients with CAC developed a gallstone as detected by ultrasound during the study period. In 5 patients with CAC, a mean period of 52.6 ± 28.9 mo was required for conversion from normal to a low EF. CCK-induced cystic duct spasm is the etiology for low EF in both CAC and CCC. Conclusion: Normal and low GBEF values are reproducible in long-term studies. Once the EF reaches a low value, it does not return to normal, and a normal value requires many years to become abnormal. CCK-induced cystic duct spasm is the cause of low GBEF in CAC and CCC, and the severity of EF reduction is similar for both. Exclusion of opioid intake immediately before the study is critical before attributing a low GBEF value to an irreversible GB motor dysfunction.",
keywords = "Acalculous cholecystitis, Calculous cholecystitis, Cholecystokinin, Cholescintigraphy, Gallbladder ejection fraction, Opioids",
author = "Krishnamurthy, {Gerbail T.} and Shakuntala Krishnamurthy and Paul Brown",
year = "2004",
month = "11",
day = "1",
language = "English (US)",
volume = "45",
pages = "1872--1877",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "11",

}

TY - JOUR

T1 - Constancy and variability of gallbladder ejection fraction

T2 - Impact on diagnosis and therapy

AU - Krishnamurthy, Gerbail T.

AU - Krishnamurthy, Shakuntala

AU - Brown, Paul

PY - 2004/11/1

Y1 - 2004/11/1

N2 - The main objective of this study was to test the constancy and variability of gallbladder (GB) ejection fraction (EF) in long-term studies to (a) determine whether EF ever becomes normal once it is low, (b) determine how long it takes for the EF to become abnormal once it is found to be normal, (c) explore the cause of low EF, and (d) define objective parameters for biliary and nonbiliary abdominal pain. Methods: Fifty-two patients (42 women, 10 men) who underwent quantitative cholescintigraphy twice (total studies, 104), over a mean period of 38.54 mo between studies, were chosen for retrospective analysis. They were divided into the following groups: control (n = 13; nonbiliary abdominal pain), chronic acalculous cholecystitis (CAC) (n = 27; biliary abdominal pain), chronic calculous cholecystitis (CCC) (n = 6; biliary abdominal pain), and opioid (n = 6; nonbiliary abdominal pain). The last group had received an opioid before cholecystokinin-8 (CCK-8) infusion in one study but not in the other study. A GBEF value of ≥35% was considered normal with a 3-min infusion and ≥50% as normal with a 10-min infusion of CCK-8. Results: The mean GBEF value was reproducible between the 2 sequential studies in the control group (66.0% ± 20.5% vs. 73.9% ± 17.7%), CAC group (24.4% ± 22.3% vs. 16.9% ± 10.9%), and CCC group (20.8% ± 20.9% vs. 27.5% ± 34.5%) but not in the opioid group (14.8% ± 14.6% vs. 56.5% ± 31.7%). The severity of GBEF reduction in CAC increased with time: 7.2% ± 8.1% within 12 mo, 16.1% ± 14.9% in 13-47 mo, and 23.5% ± 21.3% in 48-168 mo. None of the 27 patients with CAC developed a gallstone as detected by ultrasound during the study period. In 5 patients with CAC, a mean period of 52.6 ± 28.9 mo was required for conversion from normal to a low EF. CCK-induced cystic duct spasm is the etiology for low EF in both CAC and CCC. Conclusion: Normal and low GBEF values are reproducible in long-term studies. Once the EF reaches a low value, it does not return to normal, and a normal value requires many years to become abnormal. CCK-induced cystic duct spasm is the cause of low GBEF in CAC and CCC, and the severity of EF reduction is similar for both. Exclusion of opioid intake immediately before the study is critical before attributing a low GBEF value to an irreversible GB motor dysfunction.

AB - The main objective of this study was to test the constancy and variability of gallbladder (GB) ejection fraction (EF) in long-term studies to (a) determine whether EF ever becomes normal once it is low, (b) determine how long it takes for the EF to become abnormal once it is found to be normal, (c) explore the cause of low EF, and (d) define objective parameters for biliary and nonbiliary abdominal pain. Methods: Fifty-two patients (42 women, 10 men) who underwent quantitative cholescintigraphy twice (total studies, 104), over a mean period of 38.54 mo between studies, were chosen for retrospective analysis. They were divided into the following groups: control (n = 13; nonbiliary abdominal pain), chronic acalculous cholecystitis (CAC) (n = 27; biliary abdominal pain), chronic calculous cholecystitis (CCC) (n = 6; biliary abdominal pain), and opioid (n = 6; nonbiliary abdominal pain). The last group had received an opioid before cholecystokinin-8 (CCK-8) infusion in one study but not in the other study. A GBEF value of ≥35% was considered normal with a 3-min infusion and ≥50% as normal with a 10-min infusion of CCK-8. Results: The mean GBEF value was reproducible between the 2 sequential studies in the control group (66.0% ± 20.5% vs. 73.9% ± 17.7%), CAC group (24.4% ± 22.3% vs. 16.9% ± 10.9%), and CCC group (20.8% ± 20.9% vs. 27.5% ± 34.5%) but not in the opioid group (14.8% ± 14.6% vs. 56.5% ± 31.7%). The severity of GBEF reduction in CAC increased with time: 7.2% ± 8.1% within 12 mo, 16.1% ± 14.9% in 13-47 mo, and 23.5% ± 21.3% in 48-168 mo. None of the 27 patients with CAC developed a gallstone as detected by ultrasound during the study period. In 5 patients with CAC, a mean period of 52.6 ± 28.9 mo was required for conversion from normal to a low EF. CCK-induced cystic duct spasm is the etiology for low EF in both CAC and CCC. Conclusion: Normal and low GBEF values are reproducible in long-term studies. Once the EF reaches a low value, it does not return to normal, and a normal value requires many years to become abnormal. CCK-induced cystic duct spasm is the cause of low GBEF in CAC and CCC, and the severity of EF reduction is similar for both. Exclusion of opioid intake immediately before the study is critical before attributing a low GBEF value to an irreversible GB motor dysfunction.

KW - Acalculous cholecystitis

KW - Calculous cholecystitis

KW - Cholecystokinin

KW - Cholescintigraphy

KW - Gallbladder ejection fraction

KW - Opioids

UR - http://www.scopus.com/inward/record.url?scp=16544378137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544378137&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 1872

EP - 1877

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 11

ER -